Back to Results
Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer
Lung Cancer - Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer
||Kathryn Huber MD
The purpose of this study is to compare the effects, good and/or bad, of two different ways to give radiation therapy. One of the ways is experimental, while one of them is standard. Everyone will get the chemotherapy with cisplatin and etoposide, which has been established through clinical trials to be standard drugs (chemotherapy) for this type of cancer.
- Participants must be diagnosed with small cell lung cancer.
- Participants must not have had prior chemotherapy or radiation treatment
The experimental way of giving the radiation therapy is once a day with a high dose of radiation for 7 weeks. The standard way of giving the radiation therapy is to give it twice a day for 3 weeks. Although this is the typical way that many hospitals give radiation, both ways are considered standard options at Tufts Medical Center. Everyone will get the chemotherapy with cisplatin and etoposide, which has been established through clinical trials to be standard drugs (chemotherapy) for your type of cancer. Participants will be receiving the study radiation/drugs for about 3-4 months. Following treatment, they will receive follow-up examinations at least every 3 months for 2 years, every 6 months for 3 years, and then at least every year for 5 years.